One68 Global Capital’s Valion Bio VBIO Stock Holding History

One68 Global Capital’s Portfolio VBIO Stock Details VBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-11	Closed	-$2.02K	–	19
2023 Q2	$2.02K	Hold	11	–	–	0.01%	28
2023 Q1	$2.88K	Buy	+11	New	+$7.72K	﹤0.01%	55

Other funds holding VBIO

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

One68 Global Capital's VBIO Position: Q3 2023 in Review

One68 Global Capital sold out of Valion Bio (VBIO) in Q3 2023, closing a stake of 11 shares — an estimated $2.02K sold.

One68 Global Capital first reported a position in VBIO in Q1 2023 and held it in 2 quarters. The position peaked at $2.88K in Q1 2023. 6 funds tracked by Wall St. Rank hold VBIO as of Q3 2023.

One68 Global Capital reported no remaining Valion Bio position as of Q3 2023 after selling out during the quarter.
One68 Global Capital sold 11 Valion Bio shares in Q3 2023, an estimated $2.02K.
One68 Global Capital first reported a position in Valion Bio in Q1 2023 and held it in 2 quarters.
One68 Global Capital's Valion Bio position peaked at $2.88K in Q1 2023.
6 funds tracked by Wall St. Rank held Valion Bio as of Q3 2023.

Based on One68 Global Capital's 13F filing for Q3 2023.